Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease sleep disorder
Phenotype C0004936|mental disorders
Sentences 8
PubMedID- 21494304 [sleep disturbances in patients with mental disorders].
PubMedID- 22112049 The data collections were commissioned by the norwegian department of health to evaluate the state of the national mental health care system and were not designed specifically to evaluate sleep disturbance in patients with mental disorders.
PubMedID- 25938708 Background: although melatonin is increasingly used for sleep disturbances in children with neurodevelopmental disorders, evidence on effective dose and impact on specific types of sleep disturbance is limited.
PubMedID- 23107000 Our results are in line with this definition, and with the recommendation from the nih [16], and the suggested change in the dsm-5 [17], that sleep disturbance in patients with mental disorders may be regarded as a standalone therapeutic entity comorbid to the primary mental disorder.
PubMedID- 23585985 Conclusions: the prevalence of sleep disorders in subjects with mental disorders was high.
PubMedID- 21723455 Prolonged-release melatonin remains a safe, effective therapy for the long-term treatment of sleep disorders in children with neurodevelopmental disorders.
PubMedID- 24084814 sleep disturbances interact with common mental disorders; the two are mutually exacerbating, and both must be appropriately addressed to ensure optimal outcomes for our patients.
PubMedID- 26336863 sleep disorders in neurodevelopmental disorders are usually multi-factorial and not well understood.

Page: 1